OR6L1P

Across TCGA pan-cancer cohorts, OR6L1P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR6L1P’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where OR6L1P RNA is repressed in tumor relative to normal tissue. In most cancer types OR6L1P is over-expressed in tumor, although a few such as CHOL show the opposite, repressed pattern.

CHOL are the cancer types where OR6L1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR6L1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	II,III,IV	−0.100	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

OR6L1P–CHOL

Open the CHOL breakdown →